---
title: "AEON Biopharma, Inc. (AEON.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/AEON.US.md"
symbol: "AEON.US"
name: "AEON Biopharma, Inc."
industry: "Biotechnology"
---

# AEON Biopharma, Inc. (AEON.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.aeonbiopharma.com](https://www.aeonbiopharma.com) |

## Company Profile

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -4842.36 | 560/604 | 0.11 | 0.06 | 0.05 |
| PB | -0.73 | 481/604 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-22T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.20 |
| Highest Target | 5.40 |
| Lowest Target | 5.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/AEON.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/AEON.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/AEON.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.